3134 results for «383»
3134 results
Rapid-fire clinical cases: Session 4
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...
Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...
Rapid-fire abstracts: Session 9
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...
Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...
How to achieve safe early discharge
29 Nov 2022 – From PCR London Valves 2022
Discover how to achieve safe early discharge for TAVI patients with these presentations: learn more about the need of pre-procedural planning and active post-procedural care, which ECG reading are a cause for concern, and much more!
Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
Bifurcation lesion
14 Dec 2022 – From GulfPCR-GIM 2022
Among the 3 bifurcation lesion cases presented in this GulfPCR-GIM 2022 session, find out how to deliver a trapped guidewire, how to manage a live angioplasty that turned out to be a nightmare, and how to deal with a multivessel intervention with left main bifurcation and...
Bifurcation lesion - Tools, devices and techniques
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will get you thinking about how to best plan for severe left main bifurcation and severe calcification/low ejection fraction in non-surgical candidates, and how to manage difficult decisions in left main bifurcation stenting, among others!
Treatment of multi-valve disease
29 Nov 2022 – From PCR London Valves 2022
Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction
18 Nov 2024
Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.
Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
